Affiliation:
1. Hebei University of Chinese Medicine
Abstract
Abstract
Objective. Evaluate the effectiveness of extracellular vesicles derived from mesenchymal stem cells (MSCs) in the treatment of chronic kidney disease based on meta-analysis.
Methods. We searched CNKI, Wanfang, VIP, SinoMed, PubMed, Cochrane Library, EMbase, Web of Science and other databases on randomized controlled trial (RCT) of oral traditional Chinese patent medicines and simple preparations to improve inflammatory response in patients with diabetes nephropathy. The search time was from the establishment of the database to October 2022. All researchers independently screened and extracted documents for quality evaluation. Data analysis was conducted on documents that met quality standards using Stata 16.0 software and RevMan 5.4.
Results. 12 studies (n=198) satisfied the inclusion criteria.The results demonstrated that the levels of Scr (SMD=-0.38;95%CI=-4.29,-1.87;P<0.00001),BUN (SMD =−3.68, 95%CI=−5.24, −2.13;P<0.00001),and COL-1(SMD=-5.14; 95%CI=-9.32, -0.97; P<0.00001); α-sma SMD=-4.95%, 95%CI=-5.49,-2.50;P<0.00001); TGF-β (SMD=-4.19%, 95%CI=-6.92, -1.46;P=0.003) and the apoptotic cells (SMD=-3.85%, 95%CI=-5.05, -2.65;P<0.00001) were significantly decreased in the EV group.
Conclusion. The results confirmed that MSCs-EV therapy could improve renal function and delaying kidney fibrosis in preclinical animal CKD model.
Publisher
Research Square Platform LLC
Reference40 articles.
1. BO LIU. 2021.Umbilical Cord Mesenchymal Stem-derived exosomes regulate autophagy to improve chronic kidney disease through miR-146a-5p/TRAF6 pathways[M]. ChongQing Medical University; 2021.
2. CALDAS HC, LOJUDICE FH, DIAS C, FERNANDES-CHARPIOT IMM, KAWASAKI-OYAMA BAPTISTAM, TAKIYA RSSOGAYARMC, C. M., ABBUD-FILHO M. 2017. Induced Pluripotent Stem Cells Reduce Progression of Experimental Chronic Kidney Disease but Develop Wilms' Tumors. Stem Cells Int, 2017, 7428316.
3. Quality use of medicines in patients with chronic kidney disease;CASTELINO RL;BMC Nephrol,2020
4. CHENF JI. 2021.Exosomes derived human umbilical cord mesenchymal stem cells inhibit Yap activity to delay diabetic kidney disease and the mechanism.Jiangsu University.
5. Exosome and Microvesicle-Enriched Fractions Isolated from Mesenchymal Stem Cells by Gradient Separation Showed Different Molecular Signatures and Functions on Renal Tubular Epithelial Cells;COLLINO F;Stem Cell Rev Rep,2017